There is much more to know about 1-MT as an adjuvant in anticancer therapy (2016)
Branquinho, Maryana Stephany; Coimbra, Janine Baptista; Bellé, Luziane Potrich; Clara, Renan Orsati; Moreno, Ana Carolina Ramos; Braga, Maysa; Campa, Ana 
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANQUINHO, Maryana Stephany et al. There is much more to know about 1-MT as an adjuvant in anticancer therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 02 nov. 2024. , 2016APA
Branquinho, M. S., Coimbra, J. B., Bellé, L. P., Clara, R. O., Moreno, A. C. R., Braga, M., & Campa, A. (2016). There is much more to know about 1-MT as an adjuvant in anticancer therapy. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Branquinho MS, Coimbra JB, Bellé LP, Clara RO, Moreno ACR, Braga M, Campa A. There is much more to know about 1-MT as an adjuvant in anticancer therapy. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 27 res. FCF049.[citado 2024 nov. 02 ]Vancouver
Branquinho MS, Coimbra JB, Bellé LP, Clara RO, Moreno ACR, Braga M, Campa A. There is much more to know about 1-MT as an adjuvant in anticancer therapy. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 27 res. FCF049.[citado 2024 nov. 02 ]
